Skip to main content
Equibles
MYGN logo

MYGN · Myriad Genetics Inc · Metrics

Track MYGN — free

Use MYGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MYGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.42 +0.06 (+1.79%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$327.12M
Shares
95.65M

MYGN metrics

66 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.42
Market cap
$327.12M

Price action

20 metrics
Price change (1W)
+4.0%
Price change (30D)
+6.0%
Price change (3M)
-27.4%
Price change (6M)
-30.7%
Price change (YTD)
-45.4%
Price change (1Y)
-51.3%
Trailing year
Price change (5Y)
-89.9%
52-week high
$8.18
52-week low
$2.86
Change from 52-week high
-58.9%
Change from 52-week low
+17.5%
Annualized volatility
78.8%
Annualized volatility (3M)
112.2%
Beta
1.2
RSI (14D)
46.4
Price vs SMA 50
-21.4%
Price vs SMA 200
-33.0%
Avg volume (3M)
1.86M
Relative volume
2.1
Average dollar volume
$7.47M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
95.65M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 251.0%
P / book
1.1
reciprocal yield 94.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
41.7
reciprocal yield 2.4%
Earnings yield
-35.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.1×
reciprocal yield 87.9%
EV / revenue historical average (5Y)
1.9×
reciprocal yield 53.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
68.8%
Operating margin
-12.2%
Trailing 12 months
Net margin
-14.0%
Gross profit (TTM)
$555.20M
Operating profit (TTM)
−$98.60M
Net income (TTM)
−$112.60M
Trailing 12 months
Diluted EPS (TTM)
$-1.20
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.94

Growth

11 metrics
Revenue growth YoY
-10.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$806.60M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.5%
Year over year · more shares
Revenue CAGR (3Y)
+6.7%
Revenue CAGR (5Y)
+8.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-37.1%
Return on assets
-17.6%
Debt / equity
—
Current ratio
2.2
EBITDA (TTM)
−$48.40M
Free cash flow (TTM)
—
Quick ratio
2.0
Interest coverage
-6.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$115.20M
Total assets
$638.90M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$7.70M
Capital expenditures (TTM)
$74.60M
R&D (TTM)
$105.80M
SG&A (TTM)
$569.00M
Stock compensation (TTM)
$28.70M
R&D / revenue
13.1%
Stock compensation / revenue
3.6%

Ownership (13F)

3 metrics
13F filers
196
13F filer change QoQ
-8
Institutional ownership
93.1%

Short interest

3 metrics
Short interest
8.2%
Latest settlement · 5.0 days to cover
Days to cover
5.0d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 899923 CUSIP 62855J104 13F (30d) 67 filings 67 filers Visit website Investor relations